相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Unravelling Pathophysiology of Neurological and Psychiatric Complications of COVID-19 Using Brain Organoids
Jing-Han Ng et al.
NEUROSCIENTIST (2023)
A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination
William J. Murphy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
An in-silico approach to identify the potential hot spots in SARS-CoV-2 spike RBD to block the interaction with ACE2 receptor
Antony Stalin et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients
Shobi Veleri
EXPERIMENTAL BRAIN RESEARCH (2022)
Can nutraceuticals assist treatment and improve covid-19 symptoms?
Alessio Alesci et al.
NATURAL PRODUCT RESEARCH (2022)
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Alana F. Ogata et al.
CLINICAL INFECTIOUS DISEASES (2022)
Flavonoids are promising safe therapy against COVID-19
Moza Mohamed Alzaabi et al.
PHYTOCHEMISTRY REVIEWS (2022)
Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19
Souparnika H. Manjunath et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2022)
What HIV in the Brain Can Teach Us About SARS-CoV-2 Neurological Complications?
Lena Al-Harthi et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)
Severe COVID-19: A multifaceted viral vasculopathy syndrome
Cynthia M. Magro et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2021)
Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma
Duraisamy Kempuraj et al.
BIOFACTORS (2021)
SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity
Somasundaram Raghavan et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Possible Therapeutic Effects of Adjuvant Quercetin Supplementation Against Early-Stage COVID-19 Infection: A Prospective, Randomized, Controlled, and Open-Label Study
Francesco Di Pierro et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
The Relationship Between Perceived Stress and Subjective Cognitive Decline During the COVID-19 Epidemic
Anja Podlesek et al.
FRONTIERS IN PSYCHOLOGY (2021)
Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers
Abdul Mannan Baig
JOURNAL OF MEDICAL VIROLOGY (2021)
COVID-19: dealing with a potential risk factor for chronic neurological disorders
Tommaso Schirinzi et al.
JOURNAL OF NEUROLOGY (2021)
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease
Mohammad Azizur Rahman et al.
MOLECULAR NEUROBIOLOGY (2021)
A role for quercetin in coronavirus disease 2019 (COVID-19)
Giuseppe Derosa et al.
PHYTOTHERAPY RESEARCH (2021)
Repositioning microbial biotechnology against COVID-19: the case of microbial production of flavonoids
Tobias Goris et al.
MICROBIAL BIOTECHNOLOGY (2021)
The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning
Gabriel A. de Erausquin et al.
ALZHEIMERS & DEMENTIA (2021)
COVID-19: from3 an acute to chronic disease? Potential long-term health consequences
Victoria Higgins et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2021)
In Silico Studies Reveal Antiviral Effects of Traditional Indian Spices on COVID-19
Brijesh Kumar et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19
Brittany Bodnar et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study (Publication with Expression of Concern. See vol. 401, pg. 90, 2023)
Chaolin Huang et al.
LANCET (2021)
COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation
Mohamed M. Aboudounya et al.
MEDIATORS OF INFLAMMATION (2021)
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler et al.
NATURE (2021)
Immune determinants of COVID-19 disease presentation and severity
Petter Brodin
NATURE MEDICINE (2021)
Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
Jenny Meinhardt et al.
NATURE NEUROSCIENCE (2021)
The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice
Elizabeth M. Rhea et al.
NATURE NEUROSCIENCE (2021)
Microvascular Injury in the Brains of Patients with Covid-19
Daniel P. Perl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Acute Cerebrovascular Events With COVID-19 Infection
Mandip S. Dhamoon et al.
STROKE (2021)
SARS-CoV-2-related Progressive Brain White Matter Lesion Associated with an Increased Cerebrospinal Fluid Level of IL-6
Yuwa Oka et al.
INTERNAL MEDICINE (2021)
Central nervous system manifestations in COVID-19 patients: A systematic review and meta-analysis
Shahrzad Nazari et al.
BRAIN AND BEHAVIOR (2021)
Novel Targets of SARS-CoV-2 Spike Protein in Human Fetal Brain Development Suggest Early Pregnancy Vulnerability
Parul Varma et al.
FRONTIERS IN NEUROSCIENCE (2021)
Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
Angela E. Peter et al.
FRONTIERS IN PHARMACOLOGY (2021)
Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?
Ives Charlie-Silva et al.
JOURNAL OF HAZARDOUS MATERIALS (2021)
In silico identification of SARS-CoV-2 cell entry inhibitors from selected natural antivirals
Yusuf Simsek et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2021)
SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation
Brandon J. DeOre et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2021)
Potential association of mast cells with coronavirus disease 2019
Theoharis C. Theoharides
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)
Inflammatory Cytokine Patterns Associated with Neurological Diseases in Coronavirus Disease 2019
Otavio M. Espindola et al.
ANNALS OF NEUROLOGY (2021)
Integration of heparin-binding protein and interleukin-6 in the early prediction of respiratory failure and mortality in pneumonia by SARS-CoV-2 (COVID-19)
Maria Saridaki et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Molecular docking of SARS-COV-2 Spike epitope sequences identifies heterodimeric peptide-protein complex formation with human Zo-1, TLR8 and brain specific glial proteins
Subhajit Dasgupta et al.
MEDICAL HYPOTHESES (2021)
SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein
Rayan Khaddaj-Mallat et al.
NEUROBIOLOGY OF DISEASE (2021)
Waning Immunity after the BNT162b2 Vaccine in Israel
Yair Goldberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
Einav G. Levin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Luteolin inhibits NLRP3 inflammasome activation via blocking ASC oligomerization
Mi Nam Lee et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2021)
Propolis, Bee Honey, and Their Components Protect against Coronavirus Disease 2019 (COVID-19): A Review of In Silico, In Vitro, and Clinical Studies
Amira Mohammed Ali et al.
MOLECULES (2021)
Attributes and predictors of long COVID
Carole H. Sudre et al.
NATURE MEDICINE (2021)
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
I. O. Rosas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells
Eun Seon Kim et al.
VIRUSES-BASEL (2021)
Assessing Brain Capillaries in Coronavirus Disease 2019
David W. Nauen et al.
JAMA NEUROLOGY (2021)
Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases
Seth N. Levin et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue
Theoharis C. Theoharides et al.
BIOFACTORS (2021)
Effect of SARS-CoV-2 proteins on vascular permeability
Rossana Rauti et al.
ELIFE (2021)
Anti-SARS-CoV-2 and Autoantibody Profiles in the Cerebrospinal Fluid of 3 Teenaged Patients With COVID-19 and Subacute Neuropsychiatric Symptoms
Christopher M. Bartley et al.
JAMA NEUROLOGY (2021)
SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
Yuyang Lei et al.
CIRCULATION RESEARCH (2021)
Neuropathogenesis of acute coronavirus disease 2019
Shelli F. Farhadian et al.
CURRENT OPINION IN NEUROLOGY (2021)
SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems
Anne G. Savitt et al.
FRONTIERS IN IMMUNOLOGY (2021)
Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
Ruby A. Escobedo et al.
FRONTIERS IN IMMUNOLOGY (2021)
Editorial of Special Issue Regulatory Roles of Inflammasomes in Human Diseases
Young-Su Yi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Characterizing Long COVID: Deep Phenotype of a Complex Condition
Rachel R. Deer et al.
EBIOMEDICINE (2021)
Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
Dimitrios Sagris et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Post-acute COVID-19 syndrome
Ani Nalbandian et al.
NATURE MEDICINE (2021)
Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 Spike protein
Jessica Gasparello et al.
PHYTOMEDICINE (2021)
Flavonoids as potential phytotherapeutics to combat cytokine storm in SARS-CoV-2
Abhishek Gour et al.
PHYTOTHERAPY RESEARCH (2021)
SARS-CoV-2 infection, neuropathogenesis and transmission among deer mice: Implications for spillback to New World rodents
Anna Fagre et al.
PLOS PATHOGENS (2021)
Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis
George B. Stefano et al.
MEDICAL SCIENCE MONITOR (2021)
SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
Andrew Letizia et al.
LANCET RESPIRATORY MEDICINE (2021)
SARS-CoV-2 targets glial cells in human cortical organoids
Courtney L. McMahon et al.
STEM CELL REPORTS (2021)
Neuropathophysiology of coronavirus dsease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection
Menizibeya O. Welcome et al.
INFLAMMOPHARMACOLOGY (2021)
Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 long haulers
Edith L. Graham et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
IL-6 Inhibition Reduces Neuronal Injury in a Murine Model of Ventilator-induced Lung Injury
Nicklaus A. Sparrow et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)
Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant
Susmit Mhatre et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2021)
Targeting neuropilins as a viable SARS-CoV-2 treatment
Sarvenaz Sarabipour et al.
FEBS JOURNAL (2021)
Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening
Yuan Xiong et al.
FITOTERAPIA (2021)
Infection-enhancing anti-SARS-CoV-2 antibodies recognize both the original Wuhan/D614G strain and Delta variants. A potential risk for mass vaccination?
Nouara Yahi et al.
JOURNAL OF INFECTION (2021)
A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications
Jennifer A. Frontera et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)
SARS-CoV-2 Spike Protein Induces Paracrine Senescence and Leukocyte Adhesion in Endothelial Cells
Keith Meyer et al.
JOURNAL OF VIROLOGY (2021)
Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease
HariOm Singh et al.
MICROBIAL PATHOGENESIS (2021)
Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19
Ying-Qi Wang et al.
MOLECULES (2021)
Dysregulation of brain and choroid plexus cell types in severe COVID-19
Andrew C. Yang et al.
NATURE (2021)
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Evdoxia Kyriazopoulou et al.
NATURE MEDICINE (2021)
SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Confronting Our Next National Health Disaster - Long-Haul Covid
Steven Phillips et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT
Melanie L. Bell et al.
PLOS ONE (2021)
The impact of the COVID-19 pandemic on cerebrovascular disease
David I. Bass et al.
SEMINARS IN VASCULAR SURGERY (2021)
Comprehensive virtual screening of 4.8 k flavonoids reveals novel insights into allosteric inhibition of SARS-CoV-2 MPRO
Gabriel Jimenez-Avalos et al.
SCIENTIFIC REPORTS (2021)
Heparan Sulfate Proteoglycans as Attachment Factor for SARSCoV-2
Lin Liu et al.
ACS CENTRAL SCIENCE (2021)
The Role of Neuropilin-1 (NRP-1) in SARS-CoV-2 Infection: Review
Monika Gudowska-Sawczuk et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Duration of post-COVID-19 symptoms is associated with sustained SARS-CoV-2-specific immune responses
Jacob K. Files et al.
JCI INSIGHT (2021)
SARS-CoV-2: is there neuroinvasion?
Conor McQuaid et al.
FLUIDS AND BARRIERS OF THE CNS (2021)
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer
Jingwen Yue et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2021)
Ways to Address Perinatal Mast Cell Activation and Focal Brain Inflammation, including Response to SARS-CoV-2, in Autism Spectrum Disorder
Theoharis C. Theoharides
JOURNAL OF PERSONALIZED MEDICINE (2021)
SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration
Ling Zhang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
Hannah E. Davis et al.
ECLINICALMEDICINE (2021)
Immunological mechanisms of vaccine-induced protection against COVID-19 in humans
Manish Sadarangani et al.
NATURE REVIEWS IMMUNOLOGY (2021)
The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys
Li Jiao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Prediction of Anti-COVID 19 Therapeutic Power of Medicinal Moroccan Plants Using Molecular Docking
Badreddine Nouadi et al.
BIOINFORMATICS AND BIOLOGY INSIGHTS (2021)
Viral targets for vaccines against COVID-19
Lianpan Dai et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA
Maxime Taquet et al.
LANCET PSYCHIATRY (2021)
Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study
Andrea Dennis et al.
BMJ OPEN (2021)
Brain Injury-Mediated Neuroinflammatory Response and Alzheimer's Disease
Duraisamy Kempuraj et al.
NEUROSCIENTIST (2020)
The Roles of Flavonols/Flavonoids in Neurodegeneration and Neuroinflammation
Zehra Calis et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2020)
Inhibition of SARS-CoV 3CL protease by flavonoids
Seri Jo et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Extra Virgin Olive Oil Polyphenols: Modulation of Cellular Pathways Related to Oxidant Species and Inflammation in Aging
Gabriele Serreli et al.
CELLS (2020)
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms
Abdul Mannan Baig et al.
ACS CHEMICAL NEUROSCIENCE (2020)
COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin
Theoharis C. Theoharides
BIOFACTORS (2020)
The COVID-19 Pandemic: Setting the Mental Health Research Agenda
Joshua A. Gordon et al.
BIOLOGICAL PSYCHIATRY (2020)
COVID-19 pandemic and mental health consequences: Systematic review of the current evidence
Nina Vindegaard et al.
BRAIN BEHAVIOR AND IMMUNITY (2020)
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Evangelos J. Giamarellos-Bourboulis et al.
CELL HOST & MICROBE (2020)
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
Wanbo Tai et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
COVID-19 and Depression
Richard I. Shader
CLINICAL THERAPEUTICS (2020)
Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders
Anurag Kumar Singh et al.
DERMATOLOGIC THERAPY (2020)
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Tobias Herold et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines
Yunfeng Zheng et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness
Benjamin G. Druss
JAMA PSYCHIATRY (2020)
APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline
Axel Montagne et al.
NATURE (2020)
Neurologic Features in Severe SARS-CoV-2 Infection
Julie Helms et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Considerations around the SARS-CoV-2 Spike Protein with Particular Attention to COVID-19 Brain Infection and Neurological Symptoms
Kambiz Hassanzadeh et al.
ACS CHEMICAL NEUROSCIENCE (2020)
COVID-19: A Global Threat to the Nervous System
Igor J. Koralnik et al.
ANNALS OF NEUROLOGY (2020)
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Yujun Tang et al.
FRONTIERS IN IMMUNOLOGY (2020)
The COVID-19 Cytokine Storm; What We Know So Far
Dina Ragab et al.
FRONTIERS IN IMMUNOLOGY (2020)
Neurobiology of COVID-19
Majid Fotuhi et al.
JOURNAL OF ALZHEIMERS DISEASE (2020)
Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia
David H. Brann et al.
SCIENCE ADVANCES (2020)
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
Alessio Mazzoni et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Prognostic value of interleukin-6, C -reactive protein, patients with COVID-19 and procalcitonin in
Fang Liu et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports
Souhel Najjar et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Neurological associations of COVID-19
Mark A. Ellul et al.
LANCET NEUROLOGY (2020)
Roles of flavonoids against coronavirus infection
Maria Russo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Duraisamy Kempuraj et al.
NEUROSCIENTIST (2020)
Mental Health and the Covid-19 Pandemic
Betty Pfefferbaum et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Coronavirus 2019, Microthromboses, and Platelet Activating Factor
Theoharis C. Theoharides et al.
CLINICAL THERAPEUTICS (2020)
SARS-CoV-2 targets neurons of 3D human brain organoids
Anand Ramani et al.
EMBO JOURNAL (2020)
Distinct conformational states of SARS-CoV-2 spike protein
Yongfei Cai et al.
SCIENCE (2020)
Transplacental transmission of SARS-CoV-2 infection
Alexandre J. Vivanti et al.
NATURE COMMUNICATIONS (2020)
Psychiatry and COVID-19
Dost Ongur et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Highways to hell: Mechanism-based management of cytokine storm syndromes
Scott W. Canna et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
Ana Copaescu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions
T. T. Favas et al.
NEUROLOGICAL SCIENCES (2020)
Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis
Jarbas da Silva Motta Junior et al.
FRONTIERS IN IMMUNOLOGY (2020)
Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients
Eric M. Liotta et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
Deleterious Outcomes in Long-Hauler COVID-19: The Effects of SARS-CoV-2 on the CNS in Chronic COVID Syndrome
Abdul Mannan Baig
ACS CHEMICAL NEUROSCIENCE (2020)
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier
Tetyana P. Buzhdygan et al.
NEUROBIOLOGY OF DISEASE (2020)
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Bina Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Dietary flavanols improve cerebral cortical oxygenation and cognition in healthy adults
Gabriele Gratton et al.
SCIENTIFIC REPORTS (2020)
Spike Proteins of SARS-CoV and SARS-CoV-2 Utilize Different Mechanisms to Bind With Human ACE2
Yixin Xie et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
The Role of Molecular Chaperones in Virus Infection and Implications for Understanding and Treating COVID-19
Letizia Paladino et al.
JOURNAL OF CLINICAL MEDICINE (2020)
COVID-19, microthromboses, inflammation, and platelet activating factor
Constantinos Demopoulos et al.
BIOFACTORS (2020)
COVID-19 and cerebrovascular diseases: a comprehensive overview
Georgios Tsivgoulis et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)
Neuropathobiology of COVID-19: The Role for Glia
Marie-Eve Tremblay et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection
Liam Townsend et al.
PLOS ONE (2020)
Neurological manifestations of COVID-19: a systematic review
Gaurav Nepal et al.
CRITICAL CARE (2020)
COVID-19-associated brief psychotic disorder
Colin M. Smith et al.
BMJ CASE REPORTS (2020)
Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors
Huan Han et al.
EMERGING MICROBES & INFECTIONS (2020)
Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary
Spencer Richman et al.
CLINICAL THERAPEUTICS (2019)
Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?
Theoharis C. Theoharides et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Luteolin decreases the yield of influenza A virus in vitro by interfering with the coat protein I complex expression
Haiyan Yan et al.
JOURNAL OF NATURAL MEDICINES (2019)
Mast Cell Responses to Viruses and Pathogen Products
Jean S. Marshall et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome
Theoharis C. Theoharides et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Yushun Wan et al.
JOURNAL OF VIROLOGY (2019)
Luteolin Could Improve Cognitive Dysfunction by Inhibiting Neuroinflammation
Zhao-Hui Yao et al.
NEUROCHEMICAL RESEARCH (2018)
mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders
Larisa Ryskalin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The Flavone Luteolin Improves Central Nervous System Disorders by Different Mechanisms: A Review
Zeinab Ashaari et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2018)
Substance P and IL-33 administered together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin
Alexandra Taracanova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
Ana Clara Liberman et al.
NEUROIMMUNOMODULATION (2018)
Methoxyluteolin Inhibits Neuropeptide-stimulated Proinflammatory Mediator Release via mTOR Activation from Human Mast Cells
Arti B. Patel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Mast cells in neuroinflammation and brain disorders
Erik Hendriksen et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
Neuroinflammation, Mast Cells, and Glia: Dangerous Liaisons
Stephen D. Skaper et al.
NEUROSCIENTIST (2017)
A structural mechanism of flavonoids in inhibiting serine proteases
Guangpu Xue et al.
FOOD & FUNCTION (2017)
Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression
A. Mayado et al.
LEUKEMIA (2016)
Induction of Microglial Activation by Mediators Released from Mast Cells
Xiang Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
IL-6 promotes an increase in human mast cell numbers and reactivity through suppression of suppressor of cytokine signaling 3
Avanti Desai et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Activated brain mast cells contribute to postoperative cognitive dysfunction by evoking microglia activation and neuronal apoptosis
Xiang Zhang et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Luteolin protects the hippocampus against neuron impairments induced by kainic acid in rats
Tzu Yu Lin et al.
NEUROTOXICOLOGY (2016)
Neurotensin stimulates sortilin and mTOR in human microglia inhibitable by methoxyluteolin, a potential therapeutic target for autism
Arti B. Patel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Dietary Luteolin Reduces Proinflammatory Microglia in the Brain of Senescent Mice
Michael D. Burton et al.
REJUVENATION RESEARCH (2016)
Antiviral activity of luteolin against Japanese encephalitis virus
Wenchun Fan et al.
VIRUS RESEARCH (2016)
C-kit mutations determine dasatinib mechanism of action in HMC-1 neoplastic mast cells: dasatinib differently regulates PKCδ translocation in HMC-1560 and HMC-1560,816 cell lines
Araceli Tobio et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2015)
The novel flavone tetramethoxyluteolin is a potent inhibitor of human mast cells
Zuyi Weng et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Mast Cells, Mastocytosis, and Related Disorders
Theoharis C. Theoharides et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Children with autism spectrum disorders, who improved with a luteolin-containing dietary formulation, show reduced serum levels of TNF and IL-6
I. Tsilioni et al.
TRANSLATIONAL PSYCHIATRY (2015)
Brain fog, inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin
Theoharis C. Theoharides et al.
FRONTIERS IN NEUROSCIENCE (2015)
Brain Inflammation, Neuropsychiatric Disorders, and Immunoendocrine Effects of Luteolin
Theoharis C. Theoharides et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening
Lin Xu et al.
VIRUSES-BASEL (2014)
Efficacy and tolerability of Ginkgo biloba extract EGb 761 (R) in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials
Serge Gauthier et al.
CLINICAL INTERVENTIONS IN AGING (2014)
An Open-Label Pilot Study of a Formulation Containing the Anti-Inflammatory Flavonoid Luteolin and Its Effects on Behavior in Children With Autism Spectrum Disorders
Anilia Taliou et al.
CLINICAL THERAPEUTICS (2013)
Ginkgo biloba extract reduces high-glucose-induced endothelial adhesion by inhibiting the redox-dependent interleukin-6 pathways
Jia-Shiong Chen et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to Depression
Daniela Silva Moura et al.
PLOS ONE (2012)
Mast cell activation syndrome: Proposed diagnostic criteria
Cem Akin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Flavonoid-mediated presenilin-1 phosphorylation reduces Alzheimer's disease β-amyloid production
Kavon Rezai-Zadeh et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression
Kavon Rezai-Zadeh et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1
Saebyeol Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ginkgo biloba special extract EGb 761® in generalized anxiety disorder and adjustment disorder with anxious mood:: A randomized, double-blind, placebo-controlled trial
H. Woelk et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2007)
Corticotropin-releasing hormone and the blood-brain-barrier
Theoharis C. Theoharides et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Detection of severe acute respiratory syndrome coronavirus in the brain: Potential role of the chemokine mig in pathogenesis
J Xu et al.
CLINICAL INFECTIOUS DISEASES (2005)
IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis
K Brockow et al.
CLINICAL IMMUNOLOGY (2005)
Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in apolipoprotein E knockout mice
M Huang et al.
CARDIOVASCULAR RESEARCH (2003)
IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells
K Kandere-Grzybowska et al.
JOURNAL OF IMMUNOLOGY (2003)
Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients
TC Theoharides et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2002)